China Universal Asset Management Co., Ltd. Igm Biosciences, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 7,226 shares of IGMS stock, worth $10,333. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,226Holding current value
$10,333% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding IGMS
# of Institutions
83Shares Held
20.7MCall Options Held
68KPut Options Held
52.2K-
Baker Bros. Advisors LP New York, NY4.09MShares$5.85 Million0.72% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.01MShares$5.74 Million0.01% of portfolio
-
Siren, L.L.C. New York, NY3.33MShares$4.76 Million2.75% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$4.39 Million3.32% of portfolio
-
Goldman Sachs Group Inc New York, NY1.26MShares$1.8 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $41.4M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...